SWOG clinical trial number
SWOG-8268

Phase II Trial of Human Lymphoblastoid Interferon(Wellferon™) in Metastatic Renal Adenocarcinoma

Closed
Phase
Abbreviated Title
Phase II Trial of Human Lymphoblastoid Interferon(Wellferon™) in Metastatic Renal Adenocarcinoma
Activated
09/20/1982
Closed
04/25/1983

Publication Information Expand/Collapse

1984

Interferon-a therapy of renal cancer.

JA Neidhart;MM Gagen;D Young;R Tuttle;TJ Melink;A Ziccarrelli;D Kisner Cancer Res 44:4140-4143

A Phase II trial of lymphoblastoid interferon (Wellferon™) in metastatic renal adenocarcinoma. A Southwest Oncology Group study.

D Kisner;T Melink;A Ziccarrelli;M Gagen;R Tuttle;J Neidhart 4th NCI-EORTC Symposium on New Drugs in Cancer Therapy (Brussels, 1984). DD Von Hoff, ed. Investigational New Drugs 2:107

Therapy of renal cancer with low (LD), intermediate (ID), and high (HD) dose regimens of human lymphoblastoid interferon (HBLI; Wellferon*).

J Neidhart;M Gagen;D Kisner;R Tuttle;J Whisnant ASCO #C-232